SCHEMBL31311097

SCHEMBL31311097

O=C1CCCN1NS(=O)(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARL Q9H300 2/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 1/20 0.43
RCE1 Q9Y256 1/20 0.43
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ATM Q13315 1/20 0.42
CTSL P07711 1/20 0.42
CTSK P43235 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HTR7 P34969 1/20 0.40
ALDH1A1 P00352 2/20 0.40
PKM P14618 1/20 0.40
GBA1 P04062 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2084284 0.73 ATM (0.51) LMNAMEN1KMT2AHTTATM
SCHEMBL5635263 0.72 MAPT (0.51) LMNAMEN1KMT2AHTTSMN1; SMN2
Methylpyrrolidone SCHEMBL3476278 0.72 BRD4 (0.50) PARLLMNAMEN1KMT2AHPGD
SCHEMBL1829012 0.72 HTT (0.49) LMNAMEN1KMT2AHTTSMN1; SMN2
SCHEMBL7115197 0.72 LMNA (0.53) LMNAMEN1KMT2AHTTATM
SCHEMBL3799154 0.72 LMNA (0.53) LMNAMEN1KMT2AHTTATM
SCHEMBL4944309 0.71 MEN1 (0.31) LMNAMEN1KMT2AHPGD
SCHEMBL7380549 0.70 PKM (0.62) PARLLMNAMEN1KMT2ARCE1
Hydrochloric Acid SCHEMBL11538425 0.70 ATM (0.53) LMNAMEN1KMT2AHPGDHTT
SCHEMBL29174211 0.70 HTT (0.56) MEN1KMT2AHPGDHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111699189-B Modulators of beta-3 adrenergic receptors useful for treating or preventing heart failure and disorders associated therewith 艾尼纳制药公司 2025-02-18 CN disclosed